A Perspective, Single Center Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment

Conditions: Multiple Myeloma; Minimal Residual Disease Sponsors: FengYan Jin Not yet recruiting

Source: ClinicalTrials.gov - October 31, 2023 Category: Research Source Type: clinical trials